Literature DB >> 32406034

Percutaneous closure of residual atrial septal defect after surgical closure.

Soichiro Ogura1, Yoichi Takaya2, Teiji Akagi2, Koji Nakagawa2, Hiroshi Ito2.   

Abstract

Residual atrial septal defect (ASD) after surgical closure is rare, but some cases are seen during follow-up period. Redo surgery for residual ASD is often declined, while percutaneous closure can be acceptable. However, the indication of percutaneous closure for residual ASD has not been established. We reviewed our experience with percutaneous closure of residual ASD using medical and procedural records. Between 2006 and 2018, residual ASD was seen in seven patients. The median age of patients was 66 years (range 50-81 years), and the median period after surgical closure of ASD was 39 years (range 13-48 years). All patients had symptoms related to ASD. Percutaneous closure of residual ASD was successfully performed in all seven patients. No residual shunts were detected during the median follow-up period of 4.2 years (range 0.5-11 years) after percutaneous closure. Based on transesophageal echocardiographic findings and operative records for surgical closure, we considered two mechanisms causing residual ASD, such as the tear of surgical suture line and the overlooking of defect during surgical closure. Percutaneous closure of residual ASD was safely performed without any complications, suggesting that percutaneous is an effective therapeutic strategy for residual ASD after surgical closure.

Entities:  

Keywords:  Heart failure; Percutaneous closure; Residual ASD

Mesh:

Year:  2020        PMID: 32406034     DOI: 10.1007/s12928-020-00671-5

Source DB:  PubMed          Journal:  Cardiovasc Interv Ther        ISSN: 1868-4297


  1 in total

1.  Transcatheter closure for residual atrial septal defect resulting from surgical patch closure 44 years previously.

Authors:  Hiroki Matsuzoe; Hidekazu Tanaka; Keiko Hatazawa; Yutaka Hatani; Kensuke Matsumoto; Toshiro Shinke; Ken-Ichi Hirata
Journal:  J Echocardiogr       Date:  2018-01-06
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.